Revelstoke Capital Partners, a private equity firm, has completed fundraising for Revelstoke EPIC Fund III to support the growth of Rarebreed Veterinary Partners.
Revelstoke has raised $3.9 billion in equity commitments across all of its funds and has invested in 25 platform firms.
“We appreciate the significant support from a global limited partner investor base in Revelstoke’s EPIC Fund series. We are enthusiastic about Rarebreed’s growth prospects and goal of becoming the leading veterinary services platform in the United States,” said Simon Bachleda, co-founder of Revelstoke.
Houlihan Lokey Capital and SVB Securities acted as financial advisors, and Simpson Thacher & Bartlett LLP, Winston & Strawn LLP and McGuireWoods LLP provided legal counsel.